Ironwood submits MAA for linaclotide
Linaclotide is a guanylate cyclase type-C (GC-C) agonist. The company provided its efficacy and safety data from a Phase 3 program comprising two double-blind placebo-controlled trials. Over 1,600
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Regional distributors join InVitria’s worldwide distributors including Sigma-Aldrich and Thermo Fisher Scientific. The company’s distribution network will provide regional distribution options for customers in North America, Europe, Asia,